October 16, 2018 / 11:33 AM / a month ago

Chinese drug regulator fines Changsheng Bio-Tech unit over vaccine scandal

BEIJING, Oct 16 (Reuters) - China’s drug regulator imposed penalties on a unit of Changsheng Bio-Technology worth 9.1 billion yuan ($1.3 billion) over a vaccine scandal, Xinhua news agency said on Tuesday.

The penalties involved a fine and the confiscation of illegal earnings. The drug authority also banned 14 executives of Changsheng Bio-Technology from working in the drug business, Xinhua reported.

The company was accused in July of falsifying data for a rabies vaccine and manufacturing an ineffective vaccine for babies, sparking widespread consumer anger.

$1 = 6.9172 Chinese yuan renminbi Reporting by Beijing Monitoring Desk Editing by Edmund Blair

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below